<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103175</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels</dc:title>
<dc:description xml:lang="en">Introduction: Decreased levels of 25 hydroxyvitamin D (25[OH]D) have been reported in patients with chronic kidney disease (CKD). The pleiotropic effects of vitamin D are known to go beyond mineral metabolism. Objetives: The aims of this study were to: 1) Determine the 25(OH)D levels in predialysis outpatients. 2) Find out the clinical and biochemical characteristics of patients with 25(OH)D deficiency, and predictive factors for the deficiency. Patients and methods: An observational study in 79 predialysis outpatients was performed. Clinical and biochemical parameters were analysed in terms of nutrition, inflammation and mineral metabolism in relation to serum levels of 25(OH)D. Levels of 25(OH)D lower than 15ng/ml were considered to be deficient. Results: Serum levels of 25(OH)D were deficient in 41 patients (52%). The comparative study regarding levels of vitamin 25(OH)D showed the group of patients with a deficiency, i.e. those with less than 15ng/ml, were older (70 ± 11.97 vs. 61 ± 14.5; p = 0.005), had a greater body mass index, BMI, (30±4.06 vs. 27.1 ± 5.08; p = 0.003) and increased proteinuria (1.42g/24h  (..) (AU)</dc:description>
<dc:creator>Herrero, J. C</dc:creator>
<dc:creator>Sánchez, M</dc:creator>
<dc:creator>Ortiz, M</dc:creator>
<dc:creator>Rodríguez Villarreal, I</dc:creator>
<dc:creator>Ortega, O</dc:creator>
<dc:creator>Gallar, P</dc:creator>
<dc:creator>Callejas, R</dc:creator>
<dc:creator>Mon, C</dc:creator>
<dc:creator>Vigil, A</dc:creator>
<dc:creator>Gracia, C</dc:creator>
<dc:creator>Oliet, A</dc:creator>
<dc:creator>García La Calle, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Se ha descrito una disminución de los niveles de 25 hidroxivitamina D (25[OH]D) en los pacientes con enfermedad renal crónica (ERC). Conocemos que el efecto pleiotrópico de la vitamina D va más allá del metabolismo mineral. Objetivos: Los objetivos del estudio fueron: 1) determinar los niveles de 25(OH) D en pacientes con ERC seguidos en consulta de prediálisis, y 2) analizar características clínicas y bioquímicas de los pacientes con respecto a los niveles de 25(OH)D y los posibles factores predictivos de la deficiencia en 25(OH)D. Pacientes y métodos: Realizamos un estudio observacional en 79 pacientes con ERC. Analizamos datos clínicos y parámetros bioquímicos en cuanto a nutrición, inflamación y metabolismo mineral en relación con los niveles de 25(..) (AU)</dc:description>
<dc:source>Nefrologia;31(2): 185-191, abr. 2011. ilus, tab</dc:source>
<dc:identifier>ibc-103175</dc:identifier>
<dc:title xml:lang="es">Características clínicas y bioquímicas de pacientes en prediálisis con respecto a los niveles de 25 hidroxivitamina D</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d50497^s22012</dc:subject>
<dc:subject>^d10469^s22062</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11946^s22080</dc:subject>
<dc:subject>^d2146^s22062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201104</dc:date>
</metadata>
</record>
</ibecs-document>
